首页> 美国卫生研究院文献>Journal of Biomedical Research >PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease
【2h】

PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease

机译:PET示踪剂和测量冠状动脉疾病患者心肌血流的技术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Assessment of the relative distribution of myocardial flow with myocardial perfusion imaging (MPI) is methodologically limited to predict the presence or absence of flow-limited coronary artery disease (CAD). This limitation may often occur, when obstructive lesions involve multiple epicardial coronary arteries or disease-related disturbances of the coronary circulation coexist at the microvascular level. Non-invasive assessment of myocardial blood flow in absolute units with position emission tomography (PET) has been positioned as the solution to improve CAD diagnosis and prediction of patient outcomes associated with risks for cardiac events. This article reviews technical and clinical aspects of myocardial blood flow quantitation with PET and discusses the practical consideration of this approach toward worldwide clinical utilization.
机译:在方法上,用心肌灌注成像(MPI)评估心肌血流的相对分布仅限于预测是否存在血流受限的冠状动脉疾病(CAD)。当阻塞性病变累及多个心外膜冠状动脉或在微血管水平上并存与疾病相关的冠状循环障碍时,通常会出现这种局限性。使用位置发射断层扫描(PET)以绝对单位对心肌血流进行非侵入性评估已被定位为改善CAD诊断和预测与心脏事件风险相关的患者预后的解决方案。本文回顾了使用PET进行心肌血流定量的技术和临床方面,并讨论了这种方法在全球临床应用中的实际考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号